Myelodysplastic syndrome - an example of misguided immune surveillance?

被引：11

作者：

Barrett, AJ ^{[1
]}

机构：

[1] NHLBI, Stem Cell Allotransplantat Sect, Hematol Branch, NIH, Bethesda, MD 20892 USA

来源：

LEUKEMIA RESEARCH | 2004年 / 28卷 / 11期

关键词：

D O I：

10.1016/j.leukres.2004.06.001

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1123 / 1124

页数：2

共 9 条

[1]

AUNTHARARAJAH Y, 2003, BLOOD, V102, P3025

[2]

Barrett J, 2000, SEMIN HEMATOL, V37, P15

[3]

Cheson BD, 2000, BLOOD, V96, P3671

[4] Hematologic responses of patients with MDS to antithymocyte globulin plus etanercept correlate with improved flow scores of marrow cells [J].

Deeg, HJ ;

Jiang, PYZ ;

Holmberg, LA ;

Scott, B ;

Petersdorf, EW ;

Appelbaum, FR .

LEUKEMIA RESEARCH, 2004, 28 (11) :1177-1180

[5] A role for tumour necrosis factor-α, Fas and Fas-ligand in marrow failure associated with myelodysplastic syndrome [J].

Gersuk, GR ;

Beckham, C ;

Loken, MR ;

Kiener, P ;

Anderson, JE ;

Farrand, A ;

Troutt, AB ;

Ledbetter, JA ;

Deeg, HJ .

BRITISH JOURNAL OF HAEMATOLOGY, 1998, 103 (01) :176-188

[6] Cyclosporin A therapy in hypoplastic MDS patients and certain refractory anaemias without hypoplastic bone marrow [J].

Jonásová, A ;

Neuwirtová, R ;

Cermák, J ;

Vozobulová, V ;

Mociková, K ;

Sisková, M ;

Hochova, I .

BRITISH JOURNAL OF HAEMATOLOGY, 1998, 100 (02) :304-309

[7] Antithymocyte globulin for treatment of the bone marrow failure associated with myelodysplastic syndromes [J].

Molldrem, JJ ;

Leifer, E ;

Bahceci, E ;

Saunthararajah, Y ;

Rivera, M ;

Dunbar, C ;

Liu, J ;

Nakamura, R ;

Young, NS ;

Barrett, AJ .

ANNALS OF INTERNAL MEDICINE, 2002, 137 (03) :156-163

[8] Wilms tumor gene peptide-based immunotherapy for patients with overt leukemia from myelodysplastic syndrome (MDS) or MDS with myelofibrosis [J].

Oka, Y ;

Tsuboi, A ;

Murakami, M ;

Hirai, M ;

Tominaga, N ;

Nakajima, H ;

Elisseeva, OA ;

Masuda, T ;

Nakano, A ;

Kawakami, M ;

Oji, Y ;

Ikegame, K ;

Hosen, N ;

Udaka, K ;

Yasukawa, M ;

Ogawa, H ;

Kawase, L ;

Sugiyama, H .

INTERNATIONAL JOURNAL OF HEMATOLOGY, 2003, 78 (01) :56-61

[9] HLA-DR15 (DR2) is overrepresented in myelodysplastic syndrome and aplastic anemia and predicts a response to immunosuppression in myelodysplastic syndrome [J].

Saunthararajah, Y ;

Nakamura, R ;

Nam, JM ;

Robyn, J ;

Loberiza, F ;

Maciejewski, JP ;

Simonis, T ;

Molldrem, J ;

Young, NS ;

Barrett, JA .

BLOOD, 2002, 100 (05) :1570-1574

← 1 →